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Abstract
The Serum and Glucocorticoid-regulated Kinase1 (SGK1) gene is a target of the glucocorticoid receptor (GR) and is central to
the stress response in many human tissues. Because environmental stress varies across habitats, we hypothesized that
natural selection shaped the geographic distribution of genetic variants regulating the level of SGK1 expression following
GR activation. By combining population genetics and molecular biology methods, we identified a variant (rs9493857) with
marked allele frequency differences between populations of African and European ancestry and with a strong correlation
between allele frequency and latitude in worldwide population samples. This SNP is located in a GR-binding region
upstream of SGK1 that was identified using a GR ChIP-chip. SNP rs9493857 also lies within a predicted binding site for Oct1,
a transcription factor known to cooperate with the GR in the transactivation of target genes. Using ChIP assays, we show
that both GR and Oct1 bind to this region and that the ancestral allele at rs9493857 binds the GR-Oct1 complex more
efficiently than the derived allele. Finally, using a reporter gene assay, we demonstrate that the ancestral allele is associated
with increased glucocorticoid-dependent gene expression when compared to the derived allele. Our results suggest a novel
paradigm in which hormonal responsiveness is modulated by sequence variation in the regulatory regions of nuclear
receptor target genes. Identifying such functional variants may shed light on the mechanisms underlying inter-individual
variation in response to environmental stressors and to hormonal therapy, as well as in the susceptibility to hormone-
dependent diseases.
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Introduction
Substantial genetic and paleontological evidence supports the
idea that humans originated in Sub-Saharan Africa and from there
expanded across the globe ([1] and references therein). During this
dispersal, human populations encountered and settled into new
environments that differed in climate, resource availability,
pathogen exposure and other features that can challenge human
homeostasis. Additional climatic as well as lifestyle changes, e.g.
the retreat of the ice sheet and the agricultural transition, further
contributed to the environmental diversity that humans adapted
to. Many of these critical adaptations likely occurred at the genetic
level through Darwinian selection of beneficial genotypes.
When selective pressures vary across local environments, the
geographic distribution of the advantageous genotypes and the
resulting phenotypes are expected to follow distinctive patterns
that mirror the presence and intensity of the selective pressure. For
example, human skin pigmentation and body mass markedly differ
across populations and are correlated with UV radiation and
temperature, respectively [2,3]. In genome-wide studies, the
analysis of allele frequency differences between populations has
identified signals of adaptation in genes playing a role in skin
pigmentation, host-pathogen interaction, lactase persistence, etc.
[4–8]. In addition, genes that play a role in cortisol metabolism,
sodium homeostasis, and arterial vessel tone were shown to harbor
variants that are strongly correlated with latitude [9,10]. In these
analyses, latitude is considered a proxy for climate; accordingly,
these findings were interpreted as evidence for adaptation to heat
stress and dehydration. More recently, variation in candidate
genes for common metabolic disorders was also shown to be
correlated with latitude and a set of climate variables that reflect
the impact of cold and heat stress on energy homeostasis [11].
In higher organisms, homeostasis of key physiological processes
is achieved through the neuroendocrine response to environmental
challenge. This physiological response is in part mediated through
the activation of nuclear hormone receptors via a stress-induced
ligand (e.g., the adrenally secreted hormone cortisol) and
subsequent regulation of target gene expression [12]. Ultimately,
nuclear receptors and their associated cofactors, in conjunction
with cooperating transcription factors, recognize specific DNA
sequences within regulatory regions of genes encoding key
physiologic response proteins (for review see [13]). In humans,
the stress hormone cortisol mediates gene expression via the GR
and, to a lesser extent, the mineralocorticoid receptor (MR).
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and dehydration, several stress-associated kinases are activated via
rapid post-translational modification, commonly phosphorylation.
In contrast, following exposure to physiological stressors, the SGK1
gene is immediately transcriptionally induced via the ligand-bound
GR and MR, and its protein product is then constitutively
phosphorylated via endogenous PI3-K activity [14,15]. The rapid
transcriptional induction of SGK1 steady-state levels reflects
SGK1’s key role in the neuroendocrine response [16,17]. For
example, SGK1 expression regulates sodium homeostasis in the
kidney as well as enhances cell survival following exposure to
apoptotic stress such as ultraviolet light and hyperosmolality
[14,18–23]. Consistent with a key role in fundamental stress
responses, SGK1 is highly conserved across distantly related species
[24–26]. At the same time, subtle variation in SGK1’s regulatory
sequences is hypothesized to alter the threshold of SGK1’s
hormone-mediated induction, and hence increase or decrease
SGK1’s ultimate level of activity in response to a given
environmental stressor.
Under the assumption that the stress response pathway and, in
particular, the SGK1 gene were targets of local selective pressures,
we searched for genetic variants that influence SGK1 expression in
response to stress. To this end, we combined population genetics,
comparative genomics and molecular biology approaches to
identify variants in candidate regulatory region and then tested
them by means of functional assays. We found several variants
approximately 30 kb upstream of the transcriptional start site
(TSS) of SGK1 that show unusually large differences in allele
frequencies between populations and that are strongly correlated
with both latitude and climate variables. One of these variants lies
within a predicted binding site for Oct1, a transcription factor
known to cooperate with the GR [27]. We show by chromatin
immunoprecipitation (ChIP) assays that the ancestral allele of this
variant (inferred by comparison to the chimpanzee sequence)
results in more efficient binding of the GR-Oct1 complex to this
sequence. Furthermore, reporter gene expression assays reveal
higher levels of glucocorticoid-dependent transcription from the
ancestral allele compared to the derived one (i.e., the allele
inferred to have been introduced by mutation because it is not
present in chimpanzee).
Results
Identification of Candidate Regulatory Variants
We used two approaches to search for signatures of adaptation
to local environments in the genomic region surrounding the SGK1
gene. One was to quantify the difference in allele frequency
between pairs of populations by means of the FST summary
statistic [28]. The HapMap Phase II data were used in this analysis
[29]. The other approach was to measure the correlation between
allele frequencies in a large set of population samples and an
environmental variable (e.g., latitude), which was assumed to be a
good proxy for the selective pressure [11]. In this analysis, we used
the Illumina HumanHap 650Y genotype data from the Human
Genome Diversity Project (HGDP) panel [30,31]. At the genome-
wide level, the geographic distribution of allele frequencies is
mainly determined by the history of migration and population-
specific demographic events. Therefore, to distinguish between the
effect of population history alone versus that of natural selection,
we compared the geographic distribution of genetic variants in the
SGK1 region to that of variants from large genome-wide data sets.
We calculated the FST value between CEPH Europeans and
Yoruba for the SNPs in a region of 105.6 kb spanning and
upstream of the SGK1 gene. As shown in Figure 1, the FST values
for seven out of 82 SNPs in this region fall in the top 5% of the
empirical distribution for the .2 M HapMap SNPs. In particular,
only 0.2% of the HapMap SNPs have an FST value higher than
SNP rs9493857 (shown in red in Figure 1C). These results suggest
that the divergence of allele frequency between populations of
European and Sub-Saharan African ancestry in the region
upstream of SGK1 is greater than expected based on population
history alone.
To test if allele frequencies in the SGK1 upstream region also
correlate with environmental variables, we examined the SNPs
genotyped using the Illumina HumanHap 650Y chip in the
HGDP panel; in addition, we genotyped two SNPs (rs9493857
and rs1763502) in the same panel. Derived allele frequencies for
the 25 SNPs analyzed in the HGDP populations are reported in
Table S1. Following the approach described in Hancock et al.
(2008) [11], we used two different methods to assess the
relationship between allele frequency and environmental variables:
Spearman rank correlation and Bayesian geographic analysis. The
first one is a non-parametric method that does not assume a linear
relationship between the variables. The second one is a model-
based method that tests whether a linear relationship between
allele frequency and a variable provides a significantly better fit to
the data than the null model alone (where the null model is given
by a matrix of the covariance of allele frequencies between
populations). The environmental variables included latitude and
seven climate variables (see Materials and Methods) in the summer
and winter seasons; because these variables are partially
correlated, we reduced the dimensionality of the data by
calculating their principal components and used these new
variables to test the correlation with allele frequencies [11]. Eight
of the 25 SGK1 SNPs genotyped in the HGDP panel are
significantly (p,0.05) correlated with at least one of the climate
principal components or with latitude alone (Table S3). Among
them, SNP rs9493857 is the most strongly correlated with latitude
Author Summary
Susceptibility to many common human diseases including
hypertension, heart disease, and the metabolic syndrome
is associated with increased neuroendocrine signaling in
response to environmental stressors. A key component of
the human stress response involves increased systemic
glucocorticoid secretion that in turn leads to glucocorti-
coid receptor (GR) activation. As a result, a variety of GR-
expressing cell types undergo gene expression changes,
thereby providing an integrated physiological response to
stress. The SGK1 gene is a well-established GR target that
promotes cellular homeostasis in response to stress. Here,
we use a combination of population genetics and
molecular biology approaches to identify an SNP
(rs9493857) in a distant SGK1 GR-binding region with
unusually large differences in allele frequency between
populations of European and African ancestry. Further-
more, rs9493857 shows a strong correlation between allele
frequency and distance from the equator, a pattern
consistent with a varying selective advantage across
environments. Indeed, the ancestral allele at rs9493857
results in increased GR-binding and glucocorticoid-regu-
lated gene expression, suggesting that an increased stress
response (i.e., glucocorticoid responsiveness) was advan-
tageous in ancestral human populations. We speculate
that, in modern times, such variation could favor the
negative effects of a heightened glucocorticoid response,
potentially predisposing individuals to chronic diseases
such as metabolic syndrome and hypertension.
Local Adaptation in the Human SGK1 Gene
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nent 1 (Figure 2, Tables S2 and S3). The results of the Bayesian
geographic analysis provide more subtle signals, with only three of
the 25 SGK1 SNPs showing a significant linear relationship with
the climate principal components (Tables S4 and S5).
We also looked for signatures of natural selection using other
aspects of genetic variation data, including the haplotype structure
and the allele frequency spectrum [5,32–36]. Unlike the analyses
above, these tests did not detect strong signatures of positive
selection (Table S7). This may be due to the fact that these tests
are known to have inadequate power under a range of selection
scenarios; for example, when natural selection acted on recessive
variants or on variants present in the population at appreciable
frequencies prior to the onset of selection [37,38].
Overall, the analyses of the geographic distribution of allele
frequencies in the region upstream of SGK1 point to variants that
may have been targets of local adaptation. The fact that these
candidate selected variants lie in non-coding sequence and that
SGK1 activity is primarily regulated by transcriptional induction
[14,15] suggests that these variants may modulate SGK1 activity.
However, the only established GR response element (GRE) in this
region is located in the SGK1 promoter [39], while most of the
candidate SNPs are located .30 kb upstream of the TSS. To
identify additional regulatory regions beyond the promoter, we
performed a bioinformatics analysis to identify additional GREs
[40] and Evolutionary Conserved Regions (ECRs) between
human and dog, mouse, or opossum (Figure 1) [41]. We ultimately
considered only regions that contain at least two of the following
three features: high FST SNPs, predicted GREs, or ECRs. We
thereby narrowed down a region of .100 kb to three candidate
regulatory regions (respectively, 30 kb, 50 kb, and 70 kb up-
stream) spanning a total of 10 kb.
To further prioritize these three candidate regions (and possibly
identify additional ones), we performed a GR ChIP-chip assay in
MCF10A-Myc mammary epithelial cells treated with the synthetic
glucocorticoid (GC) dexamethasone (10
26 M). The immunopre-
cipitated DNA was hybridized onto the Affymetrix GeneChip
Human Tiling 2.0R A Array (which covers chromosomes 1 and 6).
GR binding regions (GBRs) were then identified using the MAT
software [42] to analyze the data obtained from two independent
experiments. By using a p-value cutoff of 10
23, ChIP-chip
identified six GBRs in the SGK1 region. Among these six GBRs,
three nonoverlapping GBRs have a MAT p-value,10
25 and also
contain two predicted GREs, three ECRs and SNP rs9493857. Of
the remaining GBRs, one is located in a region spanning intron 4
to intron 7 and contains a SNP previously implicated in risk to
Type II Diabetes and hypertension [43,44], the second is located
20 kb upstream of the TSS and is close (,1 kb) to a predicted
GRE, and the third is located 85 kb upstream of the TSS and is
5 kb away from the closest predicted GRE.
The GBRs close to a predicted GRE as well as the three
candidate regulatory regions defined above (30 kb, 50 kb, and
Figure 1. The SGK1 gene and the genomic region spanning 100 kb upstream of the TSS. (A) Predicted GR binding sites (GREs) identified by
NUBIScan. (B) GR-binding sites identified by GR ChIP-chip in MCF10A-Myc cells. The figure shows the MAT score averaged over two independent
ChIP-chip experiments. The blue bars identify the sites with a MAT score p-value,10
23. (C) FST value calculated for the Yoruba vs. CEPH European
HapMap populations on 82 HapMap Phase II SNPs. The red line indicates the 95th percentile of the FST distribution for all the HapMap Phase II SNPs
calculated in the same populations. The SNP marked by a red symbol is rs9493857. (D) Resequenced regions in 14 Italians and 14 Hausa individuals.
(E) Evolutionary Conserved Regions (ECR) between Human vs. Opossum, Mouse or Dog obtained from ECR Browser.
doi:10.1371/journal.pgen.1000489.g001
Local Adaptation in the Human SGK1 Gene
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Hausa from Cameroon and 14 Italians) to determine whether
additional variants with large allele frequency differences between
Africans and Europeans exist (see Figure 1). We identified 39 SNPs
that were not included in the HapMap data and calculated the FST
values between Hausa and Italians for all SNPs identified by
resequencing [45]. As shown in Table S6, rs9493857 retained the
highest FST value among all the SNPs present in the six surveyed
regions. Therefore, we hypothesized that rs9493857 is a target of
natural selection due to its effect on the induction of SGK1
expression in response to GR activation. This hypothesis is based
on the observation that rs9493857 has both the highest FST value
and the strongest correlation with latitude and that it resides in a
GBR.
Functional Validation of rs9493857 as a Regulatory
Variant
To validate the results of the GR ChIP-chip assay, we treated
MCF10A-Myc breast epithelial cells with either dexamethasone or
vehicle and performed a conventional GR-ChIP assay followed by
quantitative real-time PCR of the region containing SNP
rs9493857. Two independent GR-ChIP experiments showed a
significant dexamethasone-dependent enrichment for the region
containing rs9493857 (Figure 3A). The results of the conventional
ChIP assay allowed us to refine the location of the GBR to a 1 kb
region spanning rs9493857. However, this region does not contain
a predicted GRE. Therefore, we hypothesized that SNP
rs9493857 resides in a binding site for a GR cooperating
transcription factor. We used the tool P-Match [46] to search
for predicted binding sites for transcription factors and identified a
canonical Oct1 binding site that contains rs9493857. Oct1 is a
well-established GR cooperating transcription factor that can
enhance the regulation of GR target genes in a GC-dependent
manner [47]. To confirm that the region containing rs9493857 is
indeed an Oct1 binding site, we performed Oct1 ChIP
experiments in MCF10A-Myc cells treated with dexamethasone
or with vehicle. As shown in Figure 3B, the anti-Oct1
immunoprecipitated chromatin samples were enriched for the
region containing rs9493857 in a GC-dependent manner; this
enrichment was significant in all three independent experiments
(p,0.003, unpaired t-test). In contrast, no enrichment was
detected for a negative control region (Figure S1). These results,
together with the GR-ChIP results, allowed us to formulate a
model in which SNP rs9493857 affects GC-dependent Oct1
occupancy of its predicted binding site, thereby modulating GR-
dependent SGK1 gene expression.
To quantify allele-specific DNA occupancy by the GR-Oct1
complex, we next employed the HaploChIP technique, which
allows the direct comparison of two alleles within the same
heterozygous sample and the same experiment [48]. Because
MCF10A-Myc cells are not heterozygous at SNP rs9493857, we
used six lymphoblastoid cell lines (LCLs) from the HapMap
project [7] known to be heterozygous at this SNP. Figure 4 shows
the results of the GR and Oct1 HaploChIP experiments
performed in the presence of dexamethasone. The HaploChIP
experiments were performed in duplicate on 6 LCLs for the GR
and 3 LCLs for Oct1. As expected, the amount of input DNA
(starting material) was equivalent for the two alleles. However, for
both GR and Oct1 HaploChIP assays, the amount of immuno-
precipitated DNA containing the ancestral allele was significantly
greater than that containing the derived allele (p=0.019 and
p=0.016 for GR and Oct1, respectively). These results support
the conclusion that the ancestral allele at rs9493857 results in
greater DNA occupancy by the GR-Oct1 complex when
compared to the derived allele.
To test whether the newly identified GR-Oct1 binding site is
indeed a GC-dependent enhancer region for which the rs9493857
ancestral versus derived alleles convey differential transcriptional
activity, we performed luciferase reporter assays in SK-BR-3
breast cancer cells. A 3.8 kb segment encompassing rs9493857
Figure 2. Ancestral allele frequencies for rs9493857 (in black) in the 52 HGDP populations mapped onto a GIS map of Winter
Maximum Temperature (matched by hemisphere). Winter Maximum Temperature is the environmental variable with the largest contribution
to Winter Principal Component 1.
doi:10.1371/journal.pgen.1000489.g002
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luciferase gene (Figure 5). Because SK-BR-3 cells are known to
express endogenous GR at relatively high levels [16], the reporter
gene assay could be performed with endogenous GR. SK-BR-3
cells were transfected with either the DERIVED-enhancer
construct or the ANCESTRAL-enhancer construct, which were
identical except for the allele at rs9493857. Upon treatment with
dexamethasone for 12 hours, the ancestral allele at rs9493857
resulted in an average of 1.5-fold higher luciferase activity
compared to the derived allele (Figure 6) (based on four
independent experiments, p=0.002, one-tailed t-test). These
results suggest that the region ,30 kb upstream of SGK1 can in
fact act as a GC-dependent enhancer whose activity depends upon
the particular allele within the Oct1 binding site at rs9493857. In
summary, rs9493857 is located within a functional GR enhancer;
the ancestral allele at rs9493857 demonstrates both increased GR-
Oct1 binding and glucocorticoid-driven gene expression.
Discussion
We have used a combination of population genetics and
molecular biology methods to identify regulatory variants of SGK1,
a gene that plays a key role in the stress response and that has been
clearly implicated in cell survival, water re-absorption and the
Figure 3. Glucocorticoid-dependent GR and Oct1 occupancy of the region containing rs9493857. (A) GR binds the region containing
rs9493857 following dexamethasone (10
26 M) treatment in MCF10A-Myc cells. Each measurement is the average of three Q-RT-PCR technical
replicates normalized by the input DNA. The error bars represent the standard error. The results of two independent biological replicates are plotted.
(B) Oct1 binds the region containing rs9493857 following dexamethasone (10
26 M) treatment in MCF10A-Myc cells. Each measurement is the
average of three Q-RT-PCR technical replicates normalized by the input DNA. The error bars represent the standard error. The results of three
independent biological replicates are plotted.
doi:10.1371/journal.pgen.1000489.g003
Figure 4. SNP rs9493857 affects GR and Oct1 DNA occupancy following dexamethasone (10
26 M) treatment in LCLs. ChIP
experiments were performed in HapMap LCLs heterozygous for rs9493857. For each cell line (reported on the horizontal axis), the plot shows the PCR
product ratio between the Ancestral and the Derived allele at rs9493857 in the samples immunoprecipitated in the presence of the (A) anti-GR
antibody or (B) anti-Oct1 antibody and in the corresponding input samples.
doi:10.1371/journal.pgen.1000489.g004
Local Adaptation in the Human SGK1 Gene
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neuroendocrine stress response (through GR and MR activation),
we hypothesized that SGK1 regulatory variation was a target of
adaptation to environmental stress. Consistent with this hypoth-
esis, we identified a noncoding variant (rs9493857) with marked
allele frequency differences between populations and a strong
correlation with climate variables. This SNP is located within a
binding site for Oct1, a known GR cooperating transcription
factor. Using ChIP-chip, conventional ChIP, HaploChIP and
gene reporter assays, we show that the ancestral allele at
rs9493857 permits more efficient binding of the GR-Oct1
complex to the enhancer region and induces gene expression at
higher levels compared to the derived allele. More broadly, our
results show that population genetics approaches may complement
computational and traditional molecular biology methods for the
identification of regulatory variants in genes involved in the stress
response. These variants are expected to contribute to inter-
individual differences in hormone (e.g., glucocorticoid) respon-
siveness, and therefore, could contribute to individual susceptibil-
ity to common hormone-dependent diseases, such as cancer and
the metabolic syndrome.
Variation in gene regulation has long been hypothesized to be a
major mechanism in the phenotypic divergence within and
between species [49–57]. This proposal was recently bolstered
by the genome-wide identification of common variants associated
with variation in baseline mRNA levels in LCLs [58,59].
Consistent with the idea that regulatory variation may contribute
to common phenotypes, a large proportion of susceptibility
variants for common diseases identified through genome-wide
association studies lies in non-coding regions [60]. Moreover, a
number of regulatory variants have been shown to be targets of
natural selection [61–63]. More recently, it was proposed that
SNPs showing signals of selection are often associated with
variation in baseline expression levels in LCLs, suggesting that
selection of gene expression levels plays a key role in human
adaptation [64]. However, despite the important role of regulatory
variants in health and disease, the identification of such variants
continues to present a significant challenge. This is mainly because
of the dual challenge in computationally predicting regulatory
elements and inferring the functional effects of variation within
these elements. To address this problem, two main computational
approaches have been developed so far: Prediction of transcription
factor binding sites and identification of evolutionarily conserved
sequences across distantly related species. Although numerous
algorithms have been developed for the computational prediction
of transcription factor binding sites, they all suffer from a high false
positive discovery rate ([65] and references therein). When
overlaying these predictions with sequence conservation, the
number of candidate regulatory regions can be narrowed down,
but the false positive rate remains too high for experimental
follow-up. These two approaches may also be used to predict the
effect of genetic variants on gene expression levels, but the
accuracy of these predictions remains low.
Many studies aimed at the identification of variation in
regulatory sequences have focused exclusively on the proximal
promoter region of a gene (generally up to 5–10 kb upstream of
the TSS). Consistent with the idea that regulatory variation lies at
or near the promoter, genome-wide mapping studies of variation
in gene expression found that most expression quantitative trait
loci (eQTL) lie in proximity of the TSS [66]. However, it should
be noted that these studies were designed to identify eQTLs with
Figure 5. Cartoon of the 3.8 kb enhancer region located 30 kb upstream of the SGK1 TSS. The entire 3.8 kb enhancer region was used in
the reporter gene experiments. The cartoon also shows the predicted GREs, the position of rs9493857 (red) in the predicted Oct1-binding site, and
the location of the primers used to evaluate the results of the ChIP experiments.
doi:10.1371/journal.pgen.1000489.g005
Figure 6. SNP rs9493857 affects glucocorticoid-mediated
transcription. SK-BR-3 cells were transiently transfected with a
pCMV-ß-galactosidase vector and either the SGK1 enhancer ANCES-
TRAL-luciferase or the DERIVED-luciferase reporter plasmid. Cells were
split into duplicate plates and treated with either vehicle (EtOH) or
dexamethasone (10
26 M). Luciferase activity was measured as de-
scribed previously [91]. The relative luciferase activity in each condition
was normalized to ß-galactosidase activity to account for transfection
efficiency. Fold change was calculated after normalization to the pGL3
empty vector and reported as an average6standard error of four
independent experiments. **, Significant (p=0.002) one-tailed t-test.
doi:10.1371/journal.pgen.1000489.g006
Local Adaptation in the Human SGK1 Gene
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information is available about the location of eQTLs in response
to a physiological stimulus [59,66,67]. Therefore, focusing on 5–
10 kb upstream of the TSS may miss important regulatory
regions, especially for nuclear receptor target genes where long
range regulation of gene expression appears to be common [68].
In the present study, we have leveraged both molecular biology
and population genetics methods to identify a common variant
influencing GR-mediated induction of SGK1 expression. We used
computational predictions of GR binding sites and conserved
sequence elements to generate a map of candidate regulatory
elements in a .100 kb region encompassing the SGK1 gene. This
map was compared to one generated by GR ChIP-chip analysis.
ChIP-chip mapping tends to identify a smaller number of
candidate regulatory elements compared to computational
methods; however, these regions are still likely to contain a
nontrivial portion of false positives [69]. Using the signature of
natural selection to prioritize the regions identified by ChIP-chip,
we identified a likely GR enhancer region. Moreover, by
combining population genetics information with ChIP-chip, we
were able to hone in on a regulatory sequence element that
harbors common variation in human populations. Although not
all variants in GBRs are expected to carry signals of natural
selection, this approach is easily amenable to genome-wide
applications and may provide testable hypotheses either by itself
or in combination with eQTL mapping.
Given the large between-population differences in allele
frequency at rs9493857, our results imply that SGK1 expression
levels in response to cortisol could vary greatly across populations
with different ancestry. Recent eQTL mapping studies performed
on the HapMap LCLs have identified a large fraction of loci with
significant differences in mean expression levels among human
populations [59]. Although systematic differences between cell
lines from different populations may have influenced these results
[70], there is clear evidence for inter-population differences in
allele frequencies for variants associated with baseline gene
expression levels [71,72]. To investigate the contribution of
rs9493857 to SGK1 mRNA levels, we have inspected the results
of genome-wide eQTL studies in which association data are
available for all SNPs examined. We did not find a significant
association between rs9493857 genotype and SGK1 mRNA levels
[59,66,73–75]. This finding is not entirely surprising considering
that the eQTL studies assayed baseline expression levels while our
results indicate that rs9493857 influences gene expression in
response to a specific stimulus, i.e. glucocorticoid exposure.
Overall, our knowledge of inter-individual variation in expression
levels induced by the stress response remains poor.
The results of our functional studies imply that the ancestral allele
at rs9493857 will result in higher SGK1 expression levels in response
to physiological stress; this allele is also the most common allele
present in populations at lower latitudes. This finding suggests that
increased stress-induced SGK1 gene expression may have been
advantageous inancestral, and perhaps current, human populations
living in equatorial environments. Increased SGK1 expression is
consistent with SGK1’s role in mediating sodium retention;
however, SGK1 expression is also known to enhance tumor cell
survival in breast and prostate cancer cells [14,18–20,76].
Interestingly, these diverse biological processes (salt retention and
breast and prostate cell survival) underlie disease mechanisms with
known inter-population differences in incidence. For example, salt-
sensitive hypertension and prostate cancer both have a higher
prevalence in African Americans compared to other populations
[77–79]. Similarly, premenopausal African American women have
a higher proportion of the subtype of breast cancer known as ‘‘triple
negative’’, namely negative for estrogen, progesterone and Her2
receptors [80]. The lack of these three receptors suggests that
alternative growth signaling pathways drive tumor cell proliferation
in this breast cancer subtype [81]. Because the PI3-K/SGK1
pathway represents an alternative to ER-, PR- and Her2-mediated
growth signaling, increased SGK1 expression could contribute to
susceptibility to triple negative breast cancers [82].
In addition to triple negative breast cancer, African Americans,
especially African American women, have a relatively high
prevalence of the metabolic syndrome, which includes elevated
blood pressure, obesity, and type 2 diabetes [83]. The higher
prevalence in African Americans is attributed to both environ-
mental (e.g., diet) and genetic influences. There are many
similarities between patients with the metabolic syndrome and
those with excessive GC production; however, circulating cortisol
levels in the metabolic syndrome are not elevated [84]. This fact
suggests that GR signaling may be enhanced in the metabolic
syndrome independently of cortisol concentrations. Indeed, SGK1
activity has been associated with hypertension via upregulation of
epithelial sodium channel (ENaC) activity. Because small increases
in the sodium reabsorptive capacity of the renal epithelia can have
dramatic consequences on fluid volume regulation, increased
SGK1 expression might contribute to the development of
hypertension [85]. Furthermore, SGK1 activity has been linked
to diabetes through glucocorticoid-mediated inhibition of insulin
secretion [86]. Interestingly, SGK1 polymorphisms (located in both
Intron 6 and Exon 8) have recently been found to be associated
with type 2 diabetes in Romanian and German cohorts [43]. Our
finding of a GR-dependent regulatory variant in SGK1 raises the
possibility that inter-individual differences in susceptibility to
common diseases may be influenced by differential sensitivities to
GR signaling. In other words, individuals harboring alleles
resulting in increased cortisol-mediated gene expression may, as
a result, be at increased risk of some hormone-dependent diseases
such as triple negative breast cancer, prostate cancer, and the
metabolic syndrome.
The recent genome-wide association studies potentially offer an
opportunity to assess the contribution of SNP rs9493857 to
common disease phenotypes. This SNP is not present in the most
widely used genotyping platforms, thus only proxy SNPs could be
used to analyze the results of genome-wide association studies.
None of the proxy SNPs (with r
2 ranging from 0.8 to 0.6 in
Europeans) reaches genome-wide significance in the published
studies. However, two of the proxy SNPs, rs4896028 (r
2=0.811)
and rs1009840 (r
2=0.616), reach nominal levels of significance for
adult BMI (p=0.027) and glycosylated hemoglobin levels
(p=0.038) (data deposited by WTCCC and published on-line
from the British 1958 Birth Cohort DNA Collection, http://www.
b58cgene.sgul.ac.uk/), attention deficit hyperactivity disorder
(p=0.0120.001, as reported in dbGAP), and systemic lupus
erythematosus (p=0.0120.001, as reported in dbGAP) (Table
S8). Further studies are necessary to determine whether SNP
rs9493857 indeed influences susceptibility to disease phenotypes.
In particular, because this SNP affects glucocorticoid-dependent
gene expression, accounting for environmental exposures will be
important to determine conclusively if rs9493857 contributes to
phenotypic variation related to stress response.
Additional human traits and biological processes that show large
inter-population differences include skin pigmentation and energy
metabolism [2,3]. As with the stress response, these processes
occur at the interface between the organism and the environment
and are important for maintaining homeostasis. Interestingly, in
the case of SGK1, the target of natural selection appears to be the
response to a stress-induced hormonal stimulus. This raises the
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inter-population differences, may also be found in a global analysis
of genes comprising nuclear receptor gene networks. Further
studies are necessary to determine whether additional GR target
genes show similar inter-population differences in the frequency of
ancestral versus derived regulatory alleles.
Materials and Methods
Statistical and Bioinformatics Analyses
GREs were computationally predicted by using NUBIScan 2.0
[40], which implements an algorithm that relies on the
combination of nucleotide distribution weight matrices of single
hexamer halfsites for the prediction of nuclear receptor response
elements. The analysis was performed using the default GR matrix
and an arrangement consisting of two inverted repeats spaced by
three nucleotides. All the GREs with a raw score $0.6 are
reported in Figure 1A.
ECRs between human and mouse, dog or opossum were
identified using the ECR Browser tool [41].
For each SNP, FST values between pairs of populations were
calculated according to [28]; FST can vary between 0 and 1, with
FST=0 indicating no difference in allele frequencies and FST=1
indicating that alternative alleles are fixed in the two populations.
Spearman rank correlation coefficients between allele frequency
and environmental variables were calculated using an in house
program. The Bayesian geographic analysis described in Hancock
et al. (2008) [11] was applied to the SGK1 SNPs to assess the
evidence for genetic adaptation to varying environments. With
both methods, significance was assessed by comparing the value of
the test statistic for each SNP to the empirical distribution of the
same statistic for the SNPs in the Illumina Infinium HumanHap
650Y chip typed in the HGDP panel [30]. Because a shift in the
null distribution was observed for different allele frequency bins
and depending upon the genotyping panel used, significance for
each SGK1 SNP was assessed against the distribution of the test
statistic for SNPs matched by allele frequency and by panel.
Neutrality tests and summary statistics of genetic variation for the
re-sequenced regions were calculated using the program SLIDER
(http://genapps.uchicago.edu/slider/index.html). To estimate the
significance of Tajima’s D and Fay and Wu’s H, we performed
1,000 neutral simulations for each population sample separately
using the program MS [87]. For the Hausa sample we simulated a
simple growth model, while for the Italian sample we simulated a
bottleneck model. These demographic scenarios and the corre-
sponding parameter values were chosen based on previous
modeling studies showing that they are consistent with patterns of
neutral variation in the same population samples [45].
The haplotype test was performed for the re-sequenced
candidate regulatory regions as described in [36]. We performed
this test separately for each population sample. One thousand
replicates were generated under the same demographic scenarios
used above.
Re-sequencing of candidate regulatory regions. The DNA
samples sequenced at the six candidate regulatory regions belong
to a panel previously described [45,88]. A subset of this panel
consisting of 28 unrelated samples (14 Hausa from Cameroon and
14 Italians) was randomly selected.
DNA was PCR amplified and the PCR products, after Exo-
SAP purification, were sequenced with ABI BigDye Terminator
v. 3.1 Cycle Sequencing kit. The products were analyzed on an
ABI 3730 automated sequencer (Applied Biosystems) and the
resulting sequences were scored using the software Polyphred
version 6.11 [89].
Cell Lines and Cell Culture
The human breast cancer cell line SK-BR-3 was cultured in
DMEM supplemented with 10% FBS and 1% Penicillin/
Streptomycin. The human breast epithelial cell line MCF10A-
Myc was cultured in DMEM-F12 media supplemented with
growth factors as described previously [90]. Six HapMap LCLs
heterozygous at SNP rs9493857 were cultured in RPMI
supplemented with 15% FBS and 0.1% Gentamicin.
Plasmid Construction and Luciferase Assays
A 3.8 kb sequence segment upstream of the SGK1 TSS from an
Italian individual bearing the derived allele at SNP rs9493857 was
cloned in pGL3-Promoter vector (Promega) using the restriction
sites KpnI and XhoI. The resulting construct, referred to as
‘‘DERIVED,’’ was subjected to site-directed mutagenesis at the
same SNP in order to obtain a construct, referred to as
‘‘ANCESTRAL,’’ which is identical to DERIVED except for the
nucleotide at rs9493857. Site-directed mutagenesis was performed
according to the manufacturer protocol using the QuikChange II
Site-directed Mutagenesis Kit (Stratagene). All constructs were
verified by Sanger sequencing and did not contain any artifactual
mutations. DNA was prepared using the Qiagen Miniprep and
Maxiprep kits and transfected into SK-BR-3 cells using the Polyfect
Transfection Reagent (Qiagen). Luciferase and b-galactosidase
activity were measured according to standard protocols (Dual-
Luciferase Reporter Assay System and Beta-Galactosidase Enzyme
Assay, Promega) following 6, 12, and 24 hours of treatment with
either 10
26 M Dexamethasone or vehicle (ethanol) alone. Results
are given as ratios of luciferase over b-galactosidase activity. Four
independent experiments were performed and statistical signifi-
cance between dexamethasone and ethanol treated samples was
evaluated by means of a paired one-tailed t-test.
Conventional ChIP Assays
MCF10A-Myc cells (4–5610
6) and LCLs (,20610
6) were
serum starved for 48 hours and then treated with dexamethasone
10
26 M or ethanol for 1 hour. After treatment, cells were cross-
linked for 20 minutes with formaldehyde (1% final concentration)
followed by addition of glycine to a final concentration of 125 mM
for 5 minutes to arrest the cross-linking. ChIP experiments were
performed according to a standard protocol (Upstate Biotechnol-
ogy, Milipore). Rabbit polyclonal anti-GR (E-20) and anti-Oct1
(C-21) antibodies were obtained from Santa Cruz Laboratories.
The immunoprecipitated protein/chromatin complexes were
either used to perform a Western-Blot or treated to reverse the
crosslinks according to the manufacturer’s instructions. Specifical-
ly, the Western blot was performed on protein/chromatin
complexes obtained from MCF10A-Myc cells to confirm that
GR and Oct1 were immunoprecipitated only in the presence of
their specific antibodies. The DNA obtained after reversing the
crosslinks was either analyzed by quantitative RT-PCR to assess
for enrichment of the GR and Oct1 binding regions of interest
(DNA from MCF10A-Myc cells) or used to perform the
HaploChIP experiments (DNA from LCLs).
ChIP-Chip Analysis
MCF10A-Myc cells were serum-starved for 48 hours and then
treated with dexamethasone (10
26 M) for 1 hour. Following
standard ChIP, the immunoprecipitated and the input DNA were
amplified, fragmented, and labeled for hybridization according to
the Affymetrix ChIP Protocol. These samples were then
hybridized to the Affymetrix Human Tiling Array 2.0R A
(chromosome 1 and 6) and scanned at the University of Chicago
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independent biological experiments were analyzed using the
Model-based Analysis of Tiling-array (MAT) software [42] to
detect enriched regions of GR binding based on the National
Center for Biotechnology Information’s build 36 of the human
genome. The MAT software identifies ChIP-enriched regions by
calculating a MAT score for a given window size. The window size
was set to 300 bp based on our observed DNA fragment size after
shearing. For each 300 bp sliding window region, a MAT score
was calculated by pooling all of the probes across each replicate.
To assign a p-value to a window, MAT estimates the non-enriched
null distribution of all the MAT scores. To obtain the distribution,
MAT uses a non-overlapping sliding window method along the
chromosome to calculate MAT scores that cover the array.
Assuming MAT scores to be normally distributed, MAT estimates
the variance from the windows with MAT scores smaller than the
median; the null distribution is then estimated to be symmetric
around the median. A threshold of P,10
23 was used to identify
regions in chromosome 1 and 6 that are occupied by the GR.
HaploChIP
The DNA obtained by ChIP performed on LCLs treated with
dexamethasone was genotyped by means of quantitative RT-PCR
using TaqMan reagents. A custom TaqMan genotyping assay was
designed to target SNP rs9493857, with the fluorochrome VIC
identifying the ancestral allele and FAM identifying the derived
allele. To account for differences between the two fluorochromes,
a standard curve was built for each of the two alleles using serial
dilutions of a genomic DNA known to be heterozygous at
rs9493857. The resulting PCR product was quantified for each
allele separately in each reaction. The imbalance between the
ancestral and the derived alleles was measured as the ratio of the
amount of each PCR-product in the immunoprecipitated DNA to
that in the corresponding input DNA. Two independent
experiments were performed for each cell line and each
experiment result was assayed in three RT-PCR technical
replicates. Statistical significance was assessed by performing
binomial tests on 12 and 6 independent experiments, for the GR
and the Oct-1 HaploChIPs, respectively.
Genotyping Assay
Rs9493857 and rs1763502 were genotyped in 971 individuals
from 52 worldwide human populations from the CEPH Human
Genome Diversity Project (HGDP) panel [31], using an Illumina
GoldenGate assay at the UCLA Southern California Genotyping
Consortium Facility.
Supporting Information
Figure S1 Oct1 does not bind to a negative control region
following dexamethasone (10
26 M) treatment in MCF10A-Myc
cells. Each measurement is the average of three RT-PCR technical
replicates normalized to the input DNA. The error bar represents
the standard error. The results of two independent biological
replicates are plotted.
Found at: doi:10.1371/journal.pgen.1000489.s001 (3.04 MB TIF)
Table S1 Derived allele frequencies of the SGK1 SNPs
genotyped in the HGDP.
Found at: doi:10.1371/journal.pgen.1000489.s002 (0.24 MB
DOC)
Table S2 Spearman rank correlation coefficients for the SGK1
SNPs genotyped in the HGDP.
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DOC)
Table S3 Spearman rank correlation coefficients’ empirical p
values for the SGK1 SNPs genotyped in the HGDP.
Found at: doi:10.1371/journal.pgen.1000489.s004 (0.12 MB
DOC)
Table S4 Bayes Factors for the SGK1 SNPs genotyped in the
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Table S5 Bayes Factors empirical p values for the SGK1 SNPs
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DOC)
Table S6 FST values in Hausa vs. Italians for the SNPs identified
by re-sequencing.
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Table S7 Summary statistics for the six regions resequenced in
Hausa (A), Italians (B) and the overall (C) sample.
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